Acceptability of Long-Acting Injectable Antiretroviral Treatment for HIV Management: Perspectives of Patients and Physicians in Spain
Cristina Moreno(Universidad de Alcalá), Rebeca Izquierdo, Inés Suárez‐García(Centro de Investigación Biomédica en Red), Juan Macı́as(Hospital Universitario de Valme), Belén Alejos, Helena Albendín-Iglesias(Instituto Murciano de Investigación Biosanitaria), Inmaculada Jarrín(Instituto de Salud Carlos III), Begoña Alcaraz(Santa Lucía University General Hospital), Santiago Camara(McGill University), Santiago Moreno(Universidad El Bosque), Enrique Bernal(Hospital Reina Sofía de Murcia), Víctoria Hernando(Instituto de Salud Carlos III), Joaquim Peraire(Instituto de Salud Carlos III)
Cited by 12
Related Papers
Life expectancy after 2015 of adults with HIV on long-term antiretroviral therapy in Europe and North America: a collaborative analysis of cohort studies
|The Lancet HIV|2023|506
Care of patients with chronic hepatitis C and HIV co-infection: recommendations from the HIV–HCV International Panel
|AIDS|2002|443
Description of COVID-19 in HIV-infected individuals: a single-centre, prospective cohort
|The Lancet HIV|2020|396
Risk Factors and Outcomes for Late Presentation for HIV-Positive Persons in Europe: Results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE)
|PLoS Medicine|2013|362
Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores
|Nature Communications|2021|345